| RS2142461160 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142465494 |
SLC46A1
|
Health Risk |
Pathogenic |
— |
| RS2142467185 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142467231 |
SLC46A1
|
Health Risk |
Pathogenic |
— |
| RS2142473486 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2142473574 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2142474090 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2142474239 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2142474668 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2142474934 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2142474941 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2142477107 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2142477116 |
RAD51D
|
Health Risk |
Likely pathogenic |
Gastric cancer, Hereditary cancer-predisposing syndrome |
| RS2142477410 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2142480043 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS2142480064 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS2142480074 |
RAD51D
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS2142480422 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS2142480527 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS2142480699 |
CDH11
|
Health Risk |
Pathogenic |
Teebi hypertelorism syndrome 2, Teebi hypertelorism syndrome 2 |
| RS2142480769 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2142481060 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142481275 |
CDH11
|
Health Risk |
Pathogenic |
Teebi hypertelorism syndrome 2, Teebi hypertelorism syndrome 2 |
| RS2142481327 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142492118 |
CDH11
|
Health Risk |
Likely pathogenic |
Teebi hypertelorism syndrome 2, Elsahy-Waters syndrome |
| RS2142528709 |
CDH11
|
Health Risk |
Pathogenic |
Teebi hypertelorism syndrome 2, Teebi hypertelorism syndrome 2 |
| RS2142561742 |
ARMC5
|
Health Risk |
Pathogenic |
ACTH-independent macronodular adrenal hyperplasia 2, ACTH-independent macronodular adrenal hyperplasia 2 |
| RS2142562239 |
ARMC5
|
Health Risk |
Pathogenic |
ACTH-independent macronodular adrenal hyperplasia 2, ACTH-independent macronodular adrenal hyperplasia 2 |
| RS2142575218 |
ARMC5
|
Health Risk |
Likely pathogenic |
Cushing syndrome due to macronodular adrenal hyperplasia, Cushing syndrome due to macronodular adrenal hyperplasia |
| RS2142578942 |
ARMC5
|
Health Risk |
Pathogenic |
ACTH-independent macronodular adrenal hyperplasia 2, ACTH-independent macronodular adrenal hyperplasia 2 |
| RS2142580488 |
ARMC5
|
Health Risk |
Pathogenic |
ACTH-independent macronodular adrenal hyperplasia 2, ACTH-independent macronodular adrenal hyperplasia 2 |
| RS2142610073 |
PIGL
|
Health Risk |
Likely pathogenic |
CHIME syndrome, CHIME syndrome |
| RS2142631323 |
SLC5A2
|
Health Risk |
Likely pathogenic |
— |
| RS2142697 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2142701800 |
ALG1
|
Health Risk |
Likely pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS2142715856 |
ALG1
|
Health Risk |
Pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS2142716129 |
ALG1
|
Health Risk |
Likely pathogenic |
— |
| RS2142722780 |
CTU2
|
Health Risk |
Likely pathogenic |
— |
| RS2142728485 |
ALG1
|
Health Risk |
Likely pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS2142751200 |
PIEZO1
|
Health Risk |
Pathogenic |
— |
| RS2142762329 |
PIEZO1
|
Health Risk |
Likely pathogenic |
Non-immune hydrops fetalis, Non-immune hydrops fetalis |
| RS2142764905 |
PIEZO1
|
Health Risk |
Pathogenic |
— |
| RS2142767074 |
PIEZO1
|
Health Risk |
Likely pathogenic |
— |
| RS2142767103 |
TUBGCP4
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, See cases |
| RS2142795190 |
PYGL
|
Health Risk |
Pathogenic |
— |
| RS2142803273 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142808860 |
DLG4
|
Health Risk |
Pathogenic |
— |
| RS2142820621 |
PIEZO1
|
Health Risk |
Pathogenic/Likely pathogenic |
Non-immune hydrops fetalis, Non-immune hydrops fetalis |
| RS2142821543 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142821587 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142821651 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142821925 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142822298 |
DLG4
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Intellectual developmental disorder 62 |
| RS2142822830 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142823841 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142824576 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142825211 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142825224 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142825745 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142825829 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142826609 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142826656 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142827936 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, Melanoma |
| RS2142828055 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142828170 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142828228 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142828286 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142830394 |
DLG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142830670 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142830996 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual disability, Neurodevelopmental delay |
| RS2142839315 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142839453 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142839619 |
CTCF
|
Health Risk |
Likely pathogenic |
— |
| RS2142839688 |
CTCF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2142839733 |
CTCF
|
Health Risk |
Conflicting classifications of pathogenicity |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142843440 |
DLG4
|
Health Risk |
Pathogenic |
— |
| RS2142844164 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142845390 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142847326 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142847343 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142847350 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142847418 |
CTCF
|
Health Risk |
Conflicting classifications of pathogenicity |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142847512 |
CTCF
|
Health Risk |
Pathogenic/Likely pathogenic |
CTCF-related neurodevelopmental disorder, Inborn genetic diseases |
| RS2142849245 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS2142849315 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142849399 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142849423 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142849434 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142849459 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142849782 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related disorder |
| RS2142850286 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142850484 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142850736 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142850741 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142850797 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS2142850807 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142850930 |
MYBPC3
|
Health Risk |
Pathogenic |
— |
| RS2142850980 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142851045 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142851321 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |